New COVID-19 vaccines targeting the XBB variants are expected to be available by the end of September from Moderna, Pfizer and Novavax, with a change in recipe and eligibility criteria.
New COVID-19 vaccines targeting the XBB variants are expected to be available by the end of September from Moderna, Pfizer and Novavax, with a change in recipe and eligibility criteria.
Get the best of The Community Voice directly in your email inbox.
Sending to: